Caspar Stauffenberg on Bosch’s Move into Medical Diagnostics | WirtschaftsWoche

In a recent WirtschaftsWoche article on Bosch’s push into blood-based cancer diagnostics, Caspar Graf Stauffenberg, Managing Partner at Carlsquare, is quoted on why automotive suppliers can succeed in medical technology. The article also covers:

• Bosch’s plans for its Vivalytic platform and its medical business
• The challenges of entering a regulated, certification-heavy market
• What industry experts and competitors say about the strategy

Read the full article in German on WirtschaftsWoche.